SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 24 Oct 2023
Last Applicant/ Owned by
150 CambridgePark Drive, 5th Floor
Cambridge
MA
02140
Serial Number
86948315 filed on 22nd Mar 2016
Registration Number
5237897 registered on 04th Jul 2017
Correspondent Address
Chelsea E. Carbone
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
ANGIEX
Pharmaceutical research and development; Development of pharmaceutical preparations, medicines, and diagnostics; Research in the field of drugs and diagnostic preparations for detecting, imaging and treating cancer; Conducting early evaluations in the field of new pharmaceuticals and diagnostics preparations
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development; Development of pharmaceutical preparations, medicines, and diagnostics; Research in the field of drugs and diagnostic preparations for detecting, imaging and treating cancer; Conducting early evaluations in the field of new pharmaceuticals and diagnostics preparations
First Use Date in General
01st Mar 2017
First Use Date in Commerce
01st Mar 2017
Mark Details
Serial Number
No 86948315
Mark Type
No Service Mark
Attorney Docket Number
No 52628-TM1001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Oct 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 24th Oct 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 24th Oct 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 25th Apr 2023 | TEAS SECTION 8 & 15 RECEIVED |
| 04th Jul 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 04th Jul 2017 | REGISTERED-PRINCIPAL REGISTER |
| 01st Jun 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 31st May 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 18th May 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 18th May 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |